MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer

被引:71
作者
Zhang, Cailian [1 ]
Ge, Shengli [2 ]
Hu, Cailian [3 ]
Yang, Ning [1 ]
Zhang, Jinran [1 ]
机构
[1] Yanan Univ, Affiliated Hosp, Dept Geriatr, Yanan 716000, Peoples R China
[2] Yanan Univ, Affiliated Hosp, Dept Ophthalmol, Yanan 716000, Peoples R China
[3] Yanan Univ, Affiliated Hosp, Dept Pulm Med, Yanan 716000, Peoples R China
关键词
microRNA; miR-218; non-small lung cancer; HMGB1; TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; ADP-RIBOSYLATION; BREAST-CANCER; INTACT-CELLS; EXPRESSION; MICRORNA; GENES; PROTEIN; INVASIVENESS;
D O I
10.1093/abbs/gmt109
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) function as negative regulators of gene expression involved in cancer metastasis. The aim of this study is to investigate the potential roles of miR-218 in non-small cell lung cancer and validate its regulation mechanism. Functional studies showed that miR-218 overexpression inhibited cell migration and invasion, but had no effect on cell viability. Enhanced green fluorescent protein reporter assay, real-time polymerase chain reaction and western blot analysis confirmed that miR-218 suppressed the expression of high mobility group box-1 (HMGB1) by directly targeting its 3'-untranslated region. Accordingly, silencing of HMGB1 accorded with the effects of miR-218 on cell migration and invasion, and overexpression of HMGB1 can restore cell migration and invasion which were reduced by miR-218. In conclusion, these findings demonstrate that miR-218 functions as a tumor suppressor in lung cancer. Furthermore, miR-218 may act as a potential therapeutic biomarker for metastatic lung cancer patients.
引用
收藏
页码:1055 / 1061
页数:7
相关论文
共 35 条
[11]   Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers [J].
Dickinson, RE ;
Dallol, A ;
Bieche, I ;
Krex, D ;
Morton, D ;
Maher, ER ;
Latif, F .
BRITISH JOURNAL OF CANCER, 2004, 91 (12) :2071-2078
[12]   Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo [J].
Dong, Ya-Dong ;
Cui, Long ;
Peng, Cheng-Hong ;
Cheng, Dong-Feng ;
Han, Bao-San ;
Huang, Fang .
ONCOLOGY REPORTS, 2013, 29 (01) :87-94
[13]   The active gene that encodes human high mobility group 1 protein (HMG1) contains introns and maps to chromosome 13 [J].
Ferrari, S ;
Finelli, P ;
Rocchi, M ;
Bianchi, ME .
GENOMICS, 1996, 35 (02) :367-371
[14]  
Flohr AM, 2001, ANTICANCER RES, V21, P3881
[15]   miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma [J].
Furuta, Mayuko ;
Kozaki, Ken-ich ;
Tanaka, Shinji ;
Arii, Shigeki ;
Imoto, Issei ;
Inazawa, Johji .
CARCINOGENESIS, 2010, 31 (05) :766-776
[16]   Reduced MicroRNA-218 Expression Is Associated With High Nuclear Factor kappa B Activation in Gastric Cancer [J].
Gao, Caiping ;
Zhang, Zhiyu ;
Liu, Wenzhong ;
Xiao, Shudong ;
Gu, Weiqi ;
Lu, Hong .
CANCER, 2010, 116 (01) :41-49
[17]   Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues [J].
Guan, Peng ;
Yin, Zhihua ;
Li, Xuelian ;
Wu, Wei ;
Zhou, Baosen .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
[18]   miR-7 and miR-218 epigenetically control tumor suppressor genes RASSF1A and Claudin-6 by targeting HoxB3 in breast cancer [J].
Li, Qiaoyan ;
Zhu, Fufan ;
Chen, Puxiang .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 424 (01) :28-33
[19]   High-Mobility Group Box 1-Mediated Matrix Metalloproteinase-9 Expression in Non-Small Cell Lung Cancer Contributes to Tumor Cell Invasiveness [J].
Liu, Po-Len ;
Tsai, Jong-Rung ;
Hwang, Jhi-Jhu ;
Chou, Shah-Hwa ;
Cheng, Yu-Jen ;
Lin, Feng-Yen ;
Chen, Yuh-Lien ;
Hung, Chun-Ying ;
Chen, Wen-Chi ;
Chen, Yung-Hsiang ;
Chong, Inn-Wen .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2010, 43 (05) :530-538
[20]   MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1 [J].
Liu, Yanwei ;
Yan, Wei ;
Zhang, Wei ;
Chen, Lingchao ;
You, Gan ;
Bao, Zhaoshi ;
Wang, Yongzhi ;
Wang, Hongjun ;
Kang, Chunsheng ;
Jiang, Tao .
ONCOLOGY REPORTS, 2012, 28 (03) :1013-1021